missing translation for 'onlineSavingsMsg'
Learn More

CTS-1027, MedChemExpress

Product Code. 16460277
Encompass_Preferred
Click to view available options
Quantity:
5 mg
10 mg
50 mg
Unit Size:
10mg
50mg
5mg
This item is not returnable. View return policy

Product Code. 16460277

missing translation for 'mfr': Medchem Express HY10398

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

MedChemExpress CTS-1027 is a potent small molecule inhibitor of MMPs, with IC50s of 0.3 nM, 0.5 nM for MMP2, MMP13, respectively, and has > 1,000 fold selectivity over MMP1.

CTS-1027 is a potent small molecule inhibitor of MMPs, with IC50s of 0.3 nM, 0.5 nM for MMP2, MMP13, respectively, and has > 1,000 fold selectivity over MMP1.

Specifications

Chemical Name or Material CTS-1027
CAS 193022-04-7
Color White
Purity Grade Notes Research
Molecular Formula C19H20ClNO6S
Quantity 50 mg
Synonym Ro 1130830 RS 130830
Solubility Information DMSO : ≥ 100 mg/mL (234.81 mM)
SMILES O=C(NO)C1(CCOCC1)CS(=O)(C2=CC=C(C=C2)OC3=CC=C(C=C3)Cl)=O
Molecular Weight (g/mol) 425.88
Formula Weight 425.88
Percent Purity 98.45%
Grade Research
Physical Form Solid
For Use With (Application) Cancer-Kinase/protease
Show More Show Less

Research purposes only

Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.